earnings
PL
NASDAQ · PLRX
Pliant Therapeutics, Inc.
Healthcare · Biotechnology
$1.16
Up+$0.04 (+3.12%)
Updated Aug 22, 2026, 9:28 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 80.8M
- P/E ratio
- -0.46
- Dividend yield
- 0.00%
- 52-week range
- $1.02 – $1.95
- Volume
- 504.69K
- Avg. volume
- 1.08M
Price performance
PLRX price history
1M range · 21 trading sessions · Daily adjusted prices
PLRX closed at $1.16 after 21 trading sessions, up 5.96% for the selected period.
- Last close
- $1.16
- Period change
- +5.96%
- Period low
- $1.03
- Period high
- $1.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $1.12 | $1.17 | $1.12 | $1.155 | 504.69K |
| Aug 20, 2026 | $1.188 | $1.188 | $1.12 | $1.12 | 401.77K |
| Aug 19, 2026 | $1.17 | $1.20 | $1.16 | $1.17 | 681.75K |
| Aug 18, 2026 | $1.17 | $1.23 | $1.12 | $1.15 | 1.37M |
| Aug 17, 2026 | $1.07 | $1.12 | $1.07 | $1.10 | 590.77K |
| Aug 14, 2026 | $1.09 | $1.09 | $1.06 | $1.07 | 235.03K |
| Aug 13, 2026 | $1.09 | $1.10 | $1.07 | $1.08 | 557.03K |
| Aug 12, 2026 | $1.04 | $1.08 | $1.02 | $1.07 | 913.69K |
| Aug 11, 2026 | $1.05 | $1.0699 | $1.03 | $1.03 | 220.28K |
| Aug 10, 2026 | $1.05 | $1.055 | $1.03 | $1.04 | 185.13K |
| Aug 7, 2026 | $1.05 | $1.07 | $1.03 | $1.05 | 310.41K |
| Aug 6, 2026 | $1.04 | $1.07 | $1.03 | $1.05 | 639.02K |
| Aug 5, 2026 | $1.06 | $1.068 | $1.05 | $1.05 | 152.76K |
| Aug 4, 2026 | $1.05 | $1.07 | $1.035 | $1.05 | 259.71K |
| Aug 3, 2026 | $1.06 | $1.06 | $1.03 | $1.04 | 161.73K |
| Jul 31, 2026 | $1.06 | $1.08 | $1.04 | $1.04 | 334.1K |
| Jul 30, 2026 | $1.06 | $1.075 | $1.05 | $1.06 | 173.51K |
| Jul 29, 2026 | $1.08 | $1.08 | $1.05 | $1.05 | 230.48K |
| Jul 28, 2026 | $1.07 | $1.10 | $1.07 | $1.07 | 358.71K |
| Jul 27, 2026 | $1.08 | $1.11 | $1.07 | $1.08 | 208.39K |
| Jul 24, 2026 | $1.10 | $1.105 | $1.07 | $1.09 | 307.55K |
Latest PLRX news
The latest Smart Investors Daily articles mentioning PLRX.
Stock researchResearch & News · Competitors
Loading stock research…

